Median Diagnostics Inc. (XKON:233250)

Median Diagnostics Statistics

Total Valuation

XKON:233250 has a market cap or net worth of KRW 20.09 billion.

Market Cap	20.09B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:233250 has 1.75 million shares outstanding.

Current Share Class	1.75M
Shares Outstanding	1.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.18%
Owned by Institutions (%)	n/a
Float	259,012

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.56
PB Ratio	3.26
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.70.

Current Ratio	4.31
Quick Ratio	3.20
Debt / Equity	0.70
Debt / EBITDA	2.72
Debt / FCF	-3.07
Interest Coverage	2.99

Financial Efficiency

Return on equity (ROE) is -8.16% and return on invested capital (ROIC) is 6.02%.

Return on Equity (ROE)	-8.16%
Return on Assets (ROA)	4.70%
Return on Invested Capital (ROIC)	6.02%
Return on Capital Employed (ROCE)	8.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.51
Inventory Turnover	2.63

Taxes

Income Tax	-605.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.59% in the last 52 weeks. The beta is 0.17, so XKON:233250's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-20.59%
50-Day Moving Average	12,533.20
200-Day Moving Average	13,800.45
Relative Strength Index (RSI)	42.41
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:233250 had revenue of KRW 7.86 billion and -567.58 million in losses. Loss per share was -496.00.

Revenue	7.86B
Gross Profit	4.95B
Operating Income	1.17B
Pretax Income	-1.17B
Net Income	-567.58M
EBITDA	1.59B
EBIT	1.17B
Loss Per Share	-496.00

Balance Sheet

The company has 3.66 billion in cash and 4.33 billion in debt, giving a net cash position of -672.04 million or -384.79 per share.

Cash & Cash Equivalents	3.66B
Total Debt	4.33B
Net Cash	-672.04M
Net Cash Per Share	-384.79
Equity (Book Value)	6.15B
Book Value Per Share	5,378.46
Working Capital	5.11B

Cash Flow

In the last 12 months, operating cash flow was -6.05 million and capital expenditures -1.41 billion, giving a free cash flow of -1.41 billion.

Operating Cash Flow	-6.05M
Capital Expenditures	-1.41B
Free Cash Flow	-1.41B
FCF Per Share	-809.17

Margins

Gross margin is 63.01%, with operating and profit margins of 14.86% and -7.22%.

Gross Margin	63.01%
Operating Margin	14.86%
Pretax Margin	-14.93%
Profit Margin	-7.22%
EBITDA Margin	20.25%
EBIT Margin	14.86%
FCF Margin	n/a

Dividends & Yields

XKON:233250 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.83%
FCF Yield	-7.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:233250 has an Altman Z-Score of 1.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.71
Piotroski F-Score	2